← Open Payments lookup

PANDURANGA VENKATARAMANA: Open Payments

NPI 1891815775 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$368 in 12 payments from 7 companies in 2025. Trend: 2023 $400 · 2024 $711 · 2025 $368

Food & beverage: $368
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc6$153
E.R. Squibb & Sons, L.L.C.1$87
Teva Pharmaceuticals USA, Inc.1$34
Otsuka America Pharmaceutical, Inc.1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
Luye Pharma (USA) Ltd.1$22
Janssen Scientific Affairs, LLC1$12

Products named: INVEGA SUSTENNA, COBENFY, UZEDY, ABILIFY MAINTENA, CAPLYTA, SPRAVATO, ERZOFRI EXTENDED-RELEASE.

Industry payments across PA — which companies pay providers there.